Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial

Delphine Meier-Girard; Karin Ribi; Gisa Gerstenberg; Thomas Ruhstaller; Ursula Wolf

doi:10.1186/s13063-020-04542-5

Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial

Delphine Meier-Girard
, Karin Ribi
, Gisa Gerstenberg
, Thomas Ruhstaller
, Ursula Wolf

Careum Hochschule Gesundheit

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Fachzeitschrift	Trials
Jahrgang	21
Ausgabenummer	1
DOIs	https://doi.org/10.1186/s13063-020-04542-5
Publikationsstatus	Veröffentlicht - 1 Dez. 2020

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1186/s13063-020-04542-5

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04542-5

Dieses zitieren

@article{69e7d64d17dd40eab585a788b050ebd0,

title = "Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial",

author = "Delphine Meier-Girard and Karin Ribi and Gisa Gerstenberg and Thomas Ruhstaller and Ursula Wolf",

year = "2020",

month = dec,

day = "1",

doi = "10.1186/s13063-020-04542-5",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial

AU - Meier-Girard, Delphine

AU - Ribi, Karin

AU - Gerstenberg, Gisa

AU - Ruhstaller, Thomas

AU - Wolf, Ursula

PY - 2020/12/1

Y1 - 2020/12/1

U2 - 10.1186/s13063-020-04542-5

DO - 10.1186/s13063-020-04542-5

M3 - Article

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

ER -